Novo Nordisk A/S

Novo Nordisk A/S - PE Ratioverified

NVO

Price:

$45.225

Market Cap:

$1.31T

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1981-04-30

Stock Exchange

NYSE

Ticker

NVO

The PE Ratio as of August 2026 (TTM) for Novo Nordisk A/S (NVO) is 11.22

According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current PE Ratio is 11.22. This represents a change of -20.30% compared to the average of 14.08 of the last 4 quarters.

Novo Nordisk A/S (NVO) Historical PE Ratio (quarterly & annually)

How has NVO PE Ratio performed in the past?

The mean historical PE Ratio of Novo Nordisk A/S over the last ten years is 25.75. The current 11.22 PE Ratio has changed 4.26% with respect to the historical average. Over the past ten years (40 quarters), NVO's PE Ratio was at its highest in in the June 2024 quarter at 55.81. The PE Ratio was at its lowest in in the March 2026 quarter at 5.28.

Quarterly (TTM)
Annual

Average

25.75

Median

23.59

Minimum

14.10

Maximum

38.25

Novo Nordisk A/S (NVO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novo Nordisk A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 49.58%

Maximum Annual PE Ratio = 38.25

Minimum Annual Increase = -48.77%

Minimum Annual PE Ratio = 14.10

Quarterly (TTM)
Annual
YearPE RatioChange
202514.10-48.77%
202427.53-26.36%
202337.39-2.26%
202238.258.26%
202135.3449.58%
202023.620.33%
201923.5523.50%
201819.07-11.96%
201721.6627.55%
201616.98-42.42%

Novo Nordisk A/S (NVO) Average PE Ratio

How has NVO PE Ratio performed in the past?

The current PE Ratio of Novo Nordisk A/S (NVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.34

5-year avg

30.52

10-year avg

25.75

Novo Nordisk A/S (NVO) PE Ratio vs. Peers

How is NVO’s PE Ratio compared to its peers?

Novo Nordisk A/S’s PE Ratio is less than Merck & Co., Inc. (36.65), less than Novartis AG (23.50), less than Abbott Laboratories (33.62), less than AstraZeneca PLC (24.25), greater than Gilead Sciences, Inc. (-50.12), less than Pfizer Inc. (33.69), less than Thermo Fisher Scientific Inc. (30.89), less than Amgen Inc. (25.17), less than Sanofi (22.82), less than GSK plc (16.02),

CompanyPE RatioMarket cap
36.65$322.21B
23.50$293.81B
33.62$180.90B
24.25$252.95B
-50.12$161.79B
33.69$145.34B
30.89$213.71B
25.17$220.37B
22.82$103.41B
16.02$103.64B

Build a custom stock screener for Novo Nordisk A/S (NVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novo Nordisk A/S (NVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Novo Nordisk A/S's PE Ratio?

How is the PE Ratio calculated for Novo Nordisk A/S (NVO)?

What is the highest PE Ratio for Novo Nordisk A/S (NVO)?

What is the 3-year average PE Ratio for Novo Nordisk A/S (NVO)?

What is the 5-year average PE Ratio for Novo Nordisk A/S (NVO)?

How does the current PE Ratio for Novo Nordisk A/S (NVO) compare to its historical average?